Nonsteroidal anti-inflammatory drugs for pain in women with endometriosis
review
OA: bronze
CC0
⤵ 229 in-corpus citations
AI-generated summary
A review of limited, very low-quality evidence found no positive effect of NSAIDs versus placebo for endometriosis pain relief in women.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
BACKGROUND: Endometriosis is a common gynaecological condition that affects women and can lead to painful symptoms and infertility. It greatly affects women's quality of life, impacting their careers, everyday activities, sexual and nonsexual relationships and fertility. Nonsteroidal anti-inflammatory drugs (NSAIDs) are most commonly used as first-line treatment for women with pain associated with endometriosis. OBJECTIVES: To assess effects of NSAIDs used for management of pain in women with endometriosis compared with placebo, other NSAIDs, other pain management drugs or no treatment. SEARCH METHODS: We searched the Cochrane Gynaecology and Fertility Group Specialised Register of Controlled Trials (October 2016), published in the Cochrane Central Register of Controlled Trials (CENTRAL) in the Cochrane Library, as well as MEDLINE (January 2008 to October 2016), Embase (date limited from 1 January 2016 to 19 October 2016, as all earlier references are included in CENTRAL output as a result of the Embase project), registers of ongoing trials and the reference lists of relevant publications. We identified no new randomised controlled trials. Unless we identify new evidence in the future, we will not update this review. SELECTION CRITERIA: We included all randomised controlled trials (RCTs) describing use of NSAIDs for management of pain associated with endometriosis in women of all ages. DATA COLLECTION AND ANALYSIS: In the 2009 update of this review, two review authors (CA and SH) independently read and extracted data from each of the included studies. We analysed cross-over trials using the inverse variance method of RevMan to calculate odds ratios for binary outcomes. MAIN RESULTS: We identified no new trials for the 2016 update. This review includes two trials, but we included only one trial, with 24 women, in the analysis.The overall risk of bias was unclear owing to lack of methodological detail. Using the GRADE method, we judged the quality of the evidence to be very low. We downgraded evidence for risk of bias and for imprecision (wide confidence intervals and evidence based on a single small trial).Comparison of NSAIDs (naproxen) versus placebo revealed no evidence of a positive effect on pain relief (odds ratio (OR) 3.27, 95% confidence interval (CI) 0.61 to 17.69; one trial, 24 women; very low-quality evidence) in women with endometriosis. Evidence indicating whether women taking NSAIDs (naproxen) were less likely to require additional analgesia (OR 0.12, 95% CI 0.01 to 1.29; one trial, 24 women; very low-quality evidence) or to experience side effects (OR 0.46, 95% CI 0.09 to 2.47; one trial, 24 women; very low-quality evidence) when compared with placebo was inconclusive.Studies provided no data on quality of life, effects on daily activities, absence from work or school, need for more invasive treatment or participant satisfaction with treatment. AUTHORS' CONCLUSIONS: Owing to lack of high-quality evidence and lack of reporting of outcomes of interest for this review, we can make no judgement as to whether NSAIDs (naproxen) are effective in managing pain caused by endometriosis. No evidence shows whether any individual NSAID is more effective than another. As shown in other Cochrane reviews, women taking NSAIDs must be aware that these drugs may cause unintended effects.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (24)
- Characteristics Related to the Prevalence of Minimal or Mild Endometriosis in Infertile Women via openalex
- Clinical Aspects of Endometriosis via openalex
- Endometriosis 1990 via openalex
- Epidemiology of endometriosis in women attending family planning clinics. via openalex
- Managing endometriosis via openalex
- Naproxen sodium in dysmenorrhea secondary to endometriosis. via openalex
- Non-steroidal anti-inflammatory drugs for pain in women with endometriosis via openalex
- Nonsteroidal anti-inflammatory drugs for pain in women with endometriosis via openalex
- Progestagens and anti-progestagens for pain associated with endometriosis via openalex
- Progestagens and anti-progestagens for pain associated with endometriosis via openalex
- Prostaglandin biosynthesis inhibitors and endometriosis via openalex
- Prostaglandins and Endometriosis via openalex
- W4255996882 via openalex
- W1489868193 via openalex
- W1495781081 via openalex
- W1969169755 via openalex
- W2066002297 via openalex
- W2093303434 via openalex
- W2094818463 via openalex
- W2109711640 via openalex
- W2130235475 via openalex
- W2477008945 via openalex
- W2603390547 via openalex
- W4248493327 via openalex
Cited by (50)
- Endometriosis: A Cancer-Like Phenomenon 2026
- Aktuelle medikamentöse Ansätze bei Endometriose 2026
- Targeting GnRHR and ESR-1 Receptors with Natural Bioactive Compounds: A Network Pharmacology and Molecular Docking Approach to Endometriosis Therapy 2026
- Modern trends in the treatment of patients with endometriosis 2026
- Resveratrol as a protective and ameliorative agent in endometriosis 2026
- Clinical Guidance Paper VVOG: Pharmacological treatment of endometriosis-related pain 2025
- Endometriosis in Adolescence: A Narrative Review of the Psychological and Clinical Implications 2025
- THE ROLE OF PHYSICAL ACTIVITY IN THE MANAGEMENT OF ENDOMETRIOSIS: A LITERATURE REVIEW 2025
- Progressively diminished estrogen signaling concordant with increased fibrosis in ectopic endometrium 2025
- Endometriosis 2025
- Endometrial regeneration and the role of the extracellular matrix: mechanisms, challenges, and future perspectives 2025
- Safety of current strategies to manage moderate to severe pain in patients with endometriosis 2025
- Association of urinary tract endometriosis with physical and mental health: a cross-sectional study 2025
- The role of self-management in endometriosis pain: insights from a cross-sectional survey in Germany, Austria, and Switzerland 2025
- Seeking support and treatment: A thematic analysis of tweets about the experience of endometriosis 2025
- A pain-reducing Kv6.4 variant spares other Kv6 channels, offering a target for uterine pain 2025
- Endometriose 2025
- Virtual reality-based pain control in endometriosis: a questionnaire-based pilot study of applications for relaxation and physical activity 2025
- Advances in the diagnosis and management of endometriosis: A comprehensive review 2025
- The connection between endometriosis and secondary dysmenorrhea 2025
- The "double-edged sword" effect of non-steroidal anti-inflammatory drugs (NSAIDs) in the treatment of endometriosis (EMS) 2025
- “I wish I didn’t have to defend myself for not being in pain all the time”: Healthcare Interactions between People with Endometriosis and General Practitioners about Therapeutic Cannabis Use: A Narrative Analysis 2024
- Neuroimmunology of Endometriosis-Associated Pain and Its Psychological Aspects 2024
- The Hallmarks of Endometriosis 2024
- Screening and identification of key biomarkers associated with endometriosis using bioinformatics and next generation sequencing data analysis 2024
- Screening and identification of key biomarkers associated with endometriosis using bioinformatics and next-generation sequencing data analysis 2024
- Management of endometriosis: a call to multidisciplinary approach 2024
- A comprehensive review comparing conventional versus traditional remedies in the treatment of endometriosis with futuristic insights 2024
- Guideline No. 445: Management of Chronic Pelvic Pain 2024
- Virtual reality-based pain control in endometriosis: a questionnaire-based pilot study of applications for relaxation and physical activity (Preprint) 2024
- Investigational drugs for the treatment of dysmenorrhea 2024
- Advances in the Diagnosis and Management of Endometriosis: A Comprehensive Review 2024
- Therapeutic effects of S-allyl-L-cysteine in a mouse endometriosis model and its immunomodulatory effects via regulation of T cell subsets and cytokine expression 2024
- Efficacy and Safety of Sanjie Analgesic Capsule in Patients with Endometriosis-Associated Pain: A Multicenter, 3:1 Randomized, Double-Blind, Placebo-Controlled Trial 2024
- Endometriose: evolução das terapias e intervenções cirúrgicas modernas 2024
- Exercise and endometriosis—is there a promising future? A narrative review 2024
- Medikamentöse Therapie der Endometriose 2024
- Prise en charge des douleurs dans le cadre de l’endométriose 2024
- Managing the neuroinflammatory pain of endometriosis in light of chronic pelvic pain 2024
- ABORDAGENS CONTEMPORÂNEAS PARA A GESTÃO DA ENDOMETRIOSE 2024
- Clues to revising the conventional diagnostic algorithm for endometriosis 2024
- Pain Management for Women with Endometriosis 2024
- Mendelian randomization Identifies RSPO3 in Serum as a Potential Target for Endometriosis 2024
- Chronic pelvic pain 2024
- Updates in Endometriosis Management 2024
- The long road of drug development for endometriosis – Pains, gains, and hopes 2024
- A review of phase II and III drugs for the treatment and management of endometriosis 2023
- Pain perception and analgesic use after cesarean delivery among women with endometriosis 2023
- Current treatments for endometriosis in South Korea: an analysis of nationwide data from 2010 to 2019 2023
- Die medikamentöse Therapie der Patientin mit Endometriose 2023
Source provenance
- europepmc
- last seen: 2026-06-04T01:30:01.192114+00:00
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
- pubmed
- last seen: 2026-05-13T22:20:37.704673+00:00
License: CC0
· commercial use OK